This research compound is a circular RNA (circRNA) encoding a CD19-specific chimeric antigen receptor (CAR). It is utilized in CAR-T cell immunotherapy development for targeting B-cell malignancies, enabling both in vitro functional studies and in vivo preclinical model research.
Target:
Others,Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted